BGLC Shares Outstanding History Table | ||||||||
Also see: BGLC Market Cap History BGLC YTD Return |
BGLC Shares Outstanding History Table | ||||||||
Also see: BGLC Market Cap History BGLC YTD Return |
BGLC Shares Outstanding History Chart | |||||||||
+36.54% CAGR Mouse over chart for data details
|
BGLC Stock Price Chart |
About BioNexus Gene Lab Corp |
BioNexus Gene Lab is a molecular diagnostics company focused on the application of functional genomics. Co.'s focus is on developing and marketing non-invasive blood tests for early detection of diseases. Co.'s non-invasive blood tests analyze changes in ribonucleic acid to detect the risk potentiality of various diseases. These diseases include cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate and colon), bowel diseases (colitis and Crohn) and osteoarthritis. This blood based genomic biomarker approach is based on the scientific observation that circulating blood reflects, in a detectable way, what is occurring throughout the body. We show 3 historical shares outstanding datapoints in our coverage of BGLC's shares outstanding history. Understanding the changing numbers of BGLC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BGLC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BGLC by allowing them to research BGLC shares outstanding history as well as any other stock in our coverage universe. |
BGLC Current Stock Quote |
Free BGLC Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
BGLC Share Performance |
Shares Outstanding Peers |
BioNexus Gene Lab (BGLC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BGXX Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.